Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.71%
#3 Helium Helium +36.73%
#4 Pons Pons +27.97%
#5 TENDIES TENDIES +22.63%
#6 龙虾 (Lobster) 龙虾 (Lobster) +22.50%
#7 o1.exchange o1.exchange +18.62%
#8 Main Street Yield Main Street Yield +17.48%
#9 Nillion Nillion +16.95%
#10 Cysic Cysic +16.26%
Coin of the day
GEKKO GEKKO
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Kedudukan dalam Saham #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Harga Saham
$9.60
Disegerakkan terakhir: 2025-05-21
Modal Pasaran
$1.08B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan OptiNose, Inc. (OPTN)

Kategori

Healthcare
Margin Operasi untuk OptiNose, Inc. (OPTN)
Margin Operasi pada August 2026 TTM: -20.86%
Menurut laporan kewangan dan harga saham terkini OptiNose, Inc., margin operasi semasa (TTM) ialah -20.86%. Pada akhir 2023, margin operasi syarikat ialah -32.05%.
Sejarah Margin Operasi untuk OptiNose, Inc. dari 2015 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
2026 (TTM) -20.86% 0.00%
2024 -20.86% -34.91%
2023 -32.05% -56.26%
2022 -73.28% -17.67%
2021 -89.01% -49.87%
2020 -177.57% -35.68%
2019 -276.06% -80.54%
2018 -1,418.83% 0.00%
2017 0.00% -100.00%
2016 53.31% -100.16%
2015 -33,031.76% 0.00%
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00% -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00% -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00% -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00% -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
22.93% -101.10%
IN
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.